22th PAGE Meeting

Glasgow - Scotland
11-14 June, 2013

View abstracts

Home / 2013 – Glasgow – Scotland / Abstracts

← Back to filters

Abstracts (19)

I-02Gauri Rao

A Proposed Adaptive Feedback Control (AFC) Algorithm for Linezolid (L) based on Population Pharmacokinetics (PK)/Pharmacodynamics (PD)/Toxicodynamics(TD)

Wednesday 10:05-11:40

I-12

Population pharmacokinetic of rifampicine in Malawian children.

Wednesday 10:05-11:40

I-33Joel Tarning

The population pharmacokinetic and pharmacodynamic properties of intramuscular artesunate and quinine in Tanzanian children with severe falciparum malaria; implications for a practical dosing regimen.

Wednesday 10:05-11:40

I-40Elodie Valade

Population Pharmacokinetics of Emtricitabine in HIV-1-infected Patients

Wednesday 10:05-11:40

II-01Thomas Dorlo

Miltefosine treatment failure in visceral leishmaniasis in Nepal is associated with low drug exposure

Wednesday 14:50-16:20

II-17

A dynamically integrative PKPD model to predict the efficacy of marbofloxacin treatment regimens for bovine Mannheimia hemolytica infection

Wednesday 14:50-16:20

II-34Monia Guidi

Impacts of environmental, clinical and genetic factors on the response to vitamin D supplementation in HIV-positive patients

Wednesday 14:50-16:20

II-48Nerea Jauregizar

Pharmacokinetic/Pharmacodynamic modeling of time-kill curves for echinocandins against Candida.

Wednesday 14:50-16:20

II-50

Population Pharmacokinetics of Piperacillin in Burn Patients

Wednesday 14:50-16:20

II-58Takayuki Katsube

Pharmacokinetic/pharmacodynamic modeling and simulation for concentration-dependent bactericidal activity of a bicyclolide, modithromycin

Wednesday 14:50-16:20

II-59Irene-Ariadne Kechagia

Population pharmacokinetic analysis of colistin after administration of inhaled colistin methanesulfonate.

Wednesday 14:50-16:20

II-61Frank Kloprogge

Population pharmacokinetics and pharmacodynamics of lumefantrine in pregnant women with uncomplicated P. falciparum malaria.

Wednesday 14:50-16:20

III-20

Simulations to investigate new Intermittent Preventive Therapy Dosing Regimens for Dihydroartemisinin-Piperaquine

Thursday 10:05-11:35

III-37Iris Minichmayr

A Microdialysate-based Integrated Model with Nonlinear Elimination for Determining Plasma and Tissue Pharmacokinetics of Linezolid in Four Distinct Populations

Thursday 10:05-11:35

IV-04

Comparison of NONMEM and Pmetrics Analysis for Aminoglycosides in Adult Patients with Cystic Fibrosis

Thursday 14:55-16:20

IV-11Eduardo Asín-Prieto

Population Pharmacokinetics of Cefuroxime in patients Undergoing Colorectal Surgery

Thursday 14:55-16:20

IV-27Margreke Brill

Population pharmacokinetic model for protein binding and subcutaneous adipose tissue distribution of cefazolin in morbidly obese and non-obese patients

Thursday 14:55-16:20

IV-48Oskar Clewe

A Model Predicting Penetration of Rifampicin from Plasma to Epithelial Lining Fluid and Alveolar Cells

Thursday 14:55-16:20

IV-52Camille Couffignal

Population pharmacokinetics of imipenem in intensive care unit patients with ventilated-associated pneumonia

Thursday 14:55-16:20